These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29054088)

  • 1. The interactions among organophosphate pesticide exposure, oxidative stress, and genetic polymorphisms of dopamine receptor D4 increase the risk of attention deficit/hyperactivity disorder in children.
    Chang CH; Yu CJ; Du JC; Chiou HC; Chen HC; Yang W; Chung MY; Chen YS; Hwang B; Mao IF; Chen ML
    Environ Res; 2018 Jan; 160():339-346. PubMed ID: 29054088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children.
    Yu CJ; Du JC; Chiou HC; Chung MY; Yang W; Chen YS; Fuh MR; Chien LC; Hwang B; Chen ML
    Andrology; 2016 Jul; 4(4):695-705. PubMed ID: 27070915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The associations among organophosphate pesticide exposure, oxidative stress, and genetic polymorphisms of paraoxonases in children with attention deficit/hyperactivity disorder.
    Chang CH; Yu CJ; Du JC; Chiou HC; Hou JW; Yang W; Chen CF; Chen HC; Chen YS; Hwang B; Chen ML
    Sci Total Environ; 2021 Jun; 773():145604. PubMed ID: 33592467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP.
    Yang JW; Jang WS; Hong SD; Ji YI; Kim DH; Park J; Kim SW; Joung YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):243-8. PubMed ID: 17850946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P; Gornick M; Lerch J; Addington A; Seal J; Greenstein D; Sharp W; Evans A; Giedd JN; Castellanos FX; Rapoport JL
    Arch Gen Psychiatry; 2007 Aug; 64(8):921-31. PubMed ID: 17679637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children.
    Cheuk DK; Li SY; Wong V
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):907-11. PubMed ID: 16917940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposome of attention deficit hyperactivity disorder in Taiwanese children: exploring risks of endocrine-disrupting chemicals.
    Waits A; Chang CH; Yu CJ; Du JC; Chiou HC; Hou JW; Yang W; Chen HC; Chen YS; Hwang B; Chen ML
    J Expo Sci Environ Epidemiol; 2022 Jan; 32(1):169-176. PubMed ID: 34267309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.
    Albrecht B; Brandeis D; Uebel-von Sandersleben H; Valko L; Heinrich H; Xu X; Drechsler R; Heise A; Kuntsi J; Müller UC; Asherson P; Steinhausen HC; Rothenberger A; Banaschewski T
    J Child Psychol Psychiatry; 2014 Aug; 55(8):914-23. PubMed ID: 24521003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DRD4 dopamine receptor alleles in Chilean students of different ethnic origin and its relation with the risk for attention deficit/hyperactivity disorder].
    Rothhammer P; Lagos LP; Espinoza-Parrilla Y; Aboitiz F; Rothhammer F
    Rev Med Chil; 2012 Oct; 140(10):1276-81. PubMed ID: 23559284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
    Kereszturi E; Király O; Csapó Z; Tárnok Z; Gádoros J; Sasvári-Székely M; Nemoda Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):11-8. PubMed ID: 17879560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From regulatory problems in infancy to attention-deficit/hyperactivity disorder in childhood: a moderating role for the dopamine D4 receptor gene?
    Becker K; Blomeyer D; El-Faddagh M; Esser G; Schmidt MH; Banaschewski T; Laucht M
    J Pediatr; 2010 May; 156(5):798-803, 803.e1-803.e2. PubMed ID: 20172533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).
    Gizer IR; Waldman ID
    J Abnorm Psychol; 2012 Nov; 121(4):1011-23. PubMed ID: 22564179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association analysis of dopamine D4 receptor gene polymorphism and attention deficit hyperactivity disorder with/without disruptive behavior disorder].
    Guan LL; Wang YF; Li J; Wang B; Yang L; Qian QJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):233-6. PubMed ID: 17572775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].
    Paz Lagos L; Silva C; Rothhammer P; Carrasco X; Llop E; Aboitiz F; Rothhammer F
    Rev Med Chil; 2011 May; 139(5):600-5. PubMed ID: 22051710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D4 Receptor Gene Polymorphism in a Sample of Egyptian Children With Attention-Deficit Hyperactivity Disorder (ADHD).
    ElBaz Mohamed F; Kamal TM; Zahra SS; Khfagy MA; Youssef AM
    J Child Neurol; 2017 Feb; 32(2):188-193. PubMed ID: 27821512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention Deficit/Hyperactivity Disorder and Urinary Nonylphenol Levels: A Case-Control Study in Taiwanese Children.
    Yu CJ; Du JC; Chiou HC; Yang SH; Liao KW; Yang W; Chung MY; Chien LC; Hwang B; Chen ML
    PLoS One; 2016; 11(2):e0149558. PubMed ID: 26890918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population.
    Bhaduri N; Das M; Sinha S; Chattopadhyay A; Gangopadhyay PK; Chaudhuri K; Singh M; Mukhopadhyay K
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):61-6. PubMed ID: 16331654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of 14 polymorphisms in the five candidate genes and attention deficit hyperactivity disorder].
    Gao XP; Su LY; Zhao AL; Luo XR; Xia K
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):617-22. PubMed ID: 19695183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.